These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Interaction between secretory leucocyte proteinase inhibitor and bronchial mucins or glycopeptides. Physiopathological implications for the protection of mucins against proteolysis by human leucocyte elastase. Van-Seuningen I, Aubert JP, Davril M. Biochem J; 1992 Feb 01; 281 ( Pt 3)(Pt 3):761-6. PubMed ID: 1346959 [Abstract] [Full Text] [Related]
4. Mucus glycoproteins from cystic fibrotic sputum. Macromolecular properties and structural 'architecture'. Thornton DJ, Sheehan JK, Lindgren H, Carlstedt I. Biochem J; 1991 Jun 15; 276 ( Pt 3)(Pt 3):667-75. PubMed ID: 2064605 [Abstract] [Full Text] [Related]
5. Comparison of physicochemical properties of purified mucus glycoproteins isolated from respiratory secretions of cystic fibrosis and asthmatic patients. Chace KV, Flux M, Sachdev GP. Biochemistry; 1985 Dec 03; 24(25):7334-41. PubMed ID: 3002452 [Abstract] [Full Text] [Related]
7. Lysozyme and lactoferrin in sputum from patients with chronic obstructive lung disease. Harbitz O, Jenssen AO, Smidsrød O. Eur J Respir Dis; 1984 Oct 03; 65(7):512-20. PubMed ID: 6489486 [Abstract] [Full Text] [Related]
8. Mucins in airway secretions from healthy and chronic bronchitic subjects. Davies JR, Hovenberg HW, Lindén CJ, Howard R, Richardson PS, Sheehan JK, Carlstedt I. Biochem J; 1996 Jan 15; 313 ( Pt 2)(Pt 2):431-9. PubMed ID: 8573075 [Abstract] [Full Text] [Related]
9. Gel-forming and cell-associated mucins: preparation for structural and functional studies. Davies JR, Wickström C, Thornton DJ. Methods Mol Biol; 2012 Jan 15; 842():27-47. PubMed ID: 22259128 [Abstract] [Full Text] [Related]
10. Evidence for the in vivo degradation of human respiratory mucins during Pseudomonas aeruginosa infection. Houdret N, Ramphal R, Scharfman A, Perini JM, Filliat M, Lamblin G, Roussel P. Biochim Biophys Acta; 1989 Jul 21; 992(1):96-105. PubMed ID: 2752044 [Abstract] [Full Text] [Related]
13. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Kirkham S, Sheehan JK, Knight D, Richardson PS, Thornton DJ. Biochem J; 2002 Feb 01; 361(Pt 3):537-46. PubMed ID: 11802783 [Abstract] [Full Text] [Related]
17. Mucus glycoproteins in bovine trachea: identification of the major mucin populations in respiratory secretions and investigation of their tissue origins. Hovenberg HW, Carlstedt I, Davies JR. Biochem J; 1997 Jan 01; 321 ( Pt 1)(Pt 1):117-23. PubMed ID: 9003409 [Abstract] [Full Text] [Related]
18. Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions. Sallenave JM, Silva A. Am J Respir Cell Mol Biol; 1993 Apr 01; 8(4):439-45. PubMed ID: 8476637 [Abstract] [Full Text] [Related]
19. The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection. Davril M, Degroote S, Humbert P, Galabert C, Dumur V, Lafitte JJ, Lamblin G, Roussel P. Glycobiology; 1999 Mar 01; 9(3):311-21. PubMed ID: 10024669 [Abstract] [Full Text] [Related]
20. Identification of two major populations of mucins in respiratory secretions. Thornton DJ, Devine PL, Hanski C, Howard M, Sheehan JK. Am J Respir Crit Care Med; 1994 Sep 01; 150(3):823-32. PubMed ID: 8087358 [Abstract] [Full Text] [Related] Page: [Next] [New Search]